Verve Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2020
Operating Revenue	7,396	7,018	6,928	6,558	3,940	3,587	Upgrade
Revenue	7,396	7,018	6,928	6,558	3,940	3,587	Upgrade
Revenue Growth (YoY)	7.59%	1.30%	5.64%	66.45%	9.84%	-12.34%	Upgrade
Cost of Revenue	5,097	4,840	4,988	4,844	3,001	2,831	Upgrade
Gross Profit	2,299	2,178	1,940	1,714	939	756	Upgrade
Selling, General & Admin	1,562	1,487	1,353	1,192	803	721	Upgrade
Operating Expenses	1,788	1,703	1,550	1,389	803	721	Upgrade
Operating Income	511	475	390	325	136	35	Upgrade
Interest Expense	-152	-146	-145	-125	-60	-52	Upgrade
Interest & Investment Income	9	9	5	8	12	8	Upgrade
Earnings From Equity Investments	12	8	7	3	3	14	Upgrade
Currency Exchange Gain (Loss)	1	-2	1	-2	-3	12	Upgrade
EBT Excluding Unusual Items	381	344	258	209	88	17	Upgrade
Merger & Restructuring Charges	-48	-13	-7	-121	-	-	Upgrade
Impairment of Goodwill	-	-	-	-	-	-197	Upgrade
Asset Writedown	-	-	-12	-	-	-	Upgrade
Other Unusual Items	-1	-1	-7	5	-9	-4	Upgrade
Pretax Income	332	330	232	93	79	-184	Upgrade
Income Tax Expense	84	80	79	20	32	-31	Upgrade
Net Income	248	250	153	73	47	-153	Upgrade
Preferred Dividends & Other Adjustments	107	474	314	50	184	222	Upgrade
Net Income to Common	141	-224	-161	23	-137	-375	Upgrade
Net Income Growth	28.50%	63.40%	109.59%	55.32%	-	-	Upgrade
Shares Outstanding (Basic)	414	402	353	350	309	254	Upgrade
Shares Outstanding (Diluted)	417	402	353	399	309	254	Upgrade
Shares Change (YoY)	12.11%	13.84%	-11.63%	29.32%	21.40%	27.43%	Upgrade
EPS (Basic)	0.34	-0.56	-0.46	0.07	-0.44	-1.48	Upgrade
EPS (Diluted)	0.34	-0.56	-0.46	0.07	-0.44	-1.48	Upgrade
Free Cash Flow	569	536	428	191	127	458	Upgrade
Free Cash Flow Per Share	1.36	1.33	1.21	0.48	0.41	1.80	Upgrade
Gross Margin	31.08%	31.03%	28.00%	26.14%	23.83%	21.08%	Upgrade
Operating Margin	6.91%	6.77%	5.63%	4.96%	3.45%	0.98%	Upgrade
Profit Margin	1.91%	-3.19%	-2.32%	0.35%	-3.48%	-10.45%	Upgrade
Free Cash Flow Margin	7.69%	7.64%	6.18%	2.91%	3.22%	12.77%	Upgrade
EBITDA	830	777	693	629	338	298	Upgrade
EBITDA Margin	11.22%	11.07%	10.00%	9.59%	8.58%	8.31%	Upgrade
D&A For EBITDA	319	302	303	304	202	263	Upgrade
EBIT	511	475	390	325	136	35	Upgrade
EBIT Margin	6.91%	6.77%	5.63%	4.96%	3.45%	0.98%	Upgrade
Effective Tax Rate	25.30%	24.24%	34.05%	21.50%	40.51%	-	Upgrade

Updated Jul 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q